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Abstract Proper cell cycle progression is safeguarded by
the oscillating activities of cyclin/cyclin-dependent kinase
complexes. An important player in the regulation of mitotic
cyclins is the anaphase-promoting complex/cyclosome
(APC/C), a multi-subunit E3 ubiquitin ligase. Prior to entry
into mitosis, the APC/C remains inactive, which allows the
accumulation of mitotic regulators. APC/C activation
requires binding to either the Cdc20 or Cdh1 adaptor
protein, which sequentially bind the APC/C and facilitate
targeting of multiple mitotic regulators for proteasomal
destruction, including Securin and Cyclin B, to ensure
proper chromosome segregation and mitotic exit. Emerging
data have indicated that the APC/C, particularly in asso-
ciation with Cdh1, also functions prior to mitotic entry.
Specifically, the APC/C-Cdh1 is activated in response to
DNA damage in G2 phase cells. These observations are in
line with in vitro and in vivo genetic studies, in which cells
lacking Cdh1 expression display various defects, including
impaired DNA repair and aberrant cell cycle checkpoints.
In this review, we summarize the current literature on
APC/C regulation in response to DNA damage, the func-
tions of APC/C-Cdh1 activation upon DNA damage, and
speculate how APC/C-Cdh1 can control cell fate in the
context of persistent DNA damage.
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Introduction
Reproduction depends on successful cell division, which is
coordinated in the cell cycle. Especially in the context of
multicellular organisms, proper control of cell cycle initi-
ation and completion is essential for successful
development and homeostasis. Research in the past dec-
ades has revealed how cell cycle progression is coordinated
by various pathways, which show extensive feedback loops
and display multiple levels of cross-talk. Despite this
complexity, the core of the cell cycle machinery is con-
stituted by a highly evolutionary conserved molecular
‘engine,’ called the cyclin/cyclin-dependent kinase (CDK)
complex [1].
Unicellular eukaryotic organisms, such as the budding
yeast S. cerevisiae, only have limited genes encoding
cyclins and CDKs. In contrast, multicellular organisms,
including mammals, express multiple different CDKs,
which are often able to bind more than one cyclin, giving
rise to a range of distinct cyclin-CDK complexes, each of
their activities characterizing discrete phases of the cell
cycle.
The activity of CDKs is regulated on multiple tran-
scriptional and post-translational levels. CDK activity is,
for instance, extensively controlled through activating
(e.g., by the CDK-activating kinase (CAK) [2, 3]) and
inhibitory phosphorylation (e.g., by the Wee1 and Myt1
kinases [4–6]). However, probably the most important
regulatory layer of oscillating CDK activity relates to the
controlled production and down-regulation of their cyclin
partners, as CDKs are typically only active when bound to
a cyclin. The controlled production and down-regulation of
cyclins also holds the key as to how the cell cycle can only
progress in a unidirectional fashion, and how S-phase and
mitosis are limited to once per cell cycle [7]. The timely
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destruction of cyclin proteins is accounted for by ubiquitin
ligation and ensuing degradation by the 26S proteasome
[8]. Ubiquitination of mitotic A- and B-type cyclins is
accounted for by the anaphase-promoting complex/cyclo-
some (APC/C), a multi-subunit E3 ubiquitin ligase. During
S and G2 phase of the cell cycle, the APC/C remains
inactive, which allows the gradual accumulation of mitotic
cyclins [9, 10]. Once cells have entered mitosis and have
properly aligned their chromosomes, the APC/C is acti-
vated and ubiquitinates—among other substrates—mitotic
cyclins, and thereby constitutes an important part of the
mitotic exit machinery, allowing cells to complete cell
division. Through this mechanism, the APC/C forms an
integral part of the machinery that ensures periodicity of
the cell cycle [8].
Recent evidence has shown that the APC/C also per-
forms additional functions, for instance in response to
DNA damage. In this review, we provide a short back-
ground on the APC/C and the cellular response to DNA
damage. Subsequently, we summarize the current literature
on APC/C-Cdh1 activation after DNA damage, and how
this affects DNA repair, checkpoint duration, and cell fate.
Structure and function of the APC/C-Cdh1
The anaphase-promoting complex/cyclosome (APC/C) is
an exceptionally large multimeric E3 ubiquitin ligase,
belonging to the ring/cullin subfamily of ubiquitin ligases
[11, 12]. As it was identified as a protein complex from
clam egg extracts that can degrade mitotic cyclins, it was
named ‘cyclosome’ [13]. Likewise, a similar 20S complex
was biochemically purified from Xenopus extracts based on
its ability to facilitate cyclin B destruction and to promote
anaphase; hence, it was named the ‘anaphase-promoting
complex’ (APC) [14]. In parallel, genetic analysis of
mutant yeast strains led to the identification of APC com-
ponents in budding yeast and fission yeast that are required
for degradation of Cyclin B and Securin during the meta-
phase-to-anaphase transition [15–17]. Currently, the term
and abbreviation anaphase-promoting complex/cyclosome
(APC/C) is used, which also prevents confusion with the
frequently mutated tumor suppressor gene APC, encoding
the Adenomatous Polyposis Coli gene product.
The APC/C is composed of 14 different subunits in
mammalian cells (Table 1), whereas alternative confor-
mations with species-specific subunits have been identified
(e.g., the budding yeast-specific subunit APC9, and the
fission yeast-specific subunit APC14) [11, 12, 18]. Addi-
tionally, the APC/C requires binding to a co-activator
(either Cdc20 or Cdh1) for catalytic activity and for sub-
strate recognition. Reconstruction using cryo-electron
microscopy recently yielded a complete overview of the
3D assembly of the APC/C [12], and confirmed the
triangular ‘shell-like’ shape (Fig. 1), that was proposed
based on earlier structural studies. Concerning the stoi-
chiometry of the APC/C, five subunits are present in two
copies (APC12 as well as the four tetratricopeptide-repeat
(TPR)-containing subunits APC3, APC6, APC7, and
APC8), whereas the other subunits are only present in one
copy [11, 19]. This conformation leads to an assembly of
19 subunits with a size of 1.22 MDa.
The ‘back’ of the APC/C complex is also referred to as
the ‘TPR’ lobe, as it harbors the four APC/C subunits with
conserved tetratricopeptide-repeat motifs (APC3, APC6,
APC7, and APC8) as well as the accessory protein APC12.
TPR motifs are widely found and consist of 34 amino
acids, which promote protein–protein interactions and
thereby are often involved in the structural organization of
multimeric protein complexes. The TPR-containing sub-
units within the APC/C are bound and correctly ordered by
the APC16 and APC13 subunits (Fig. 1) [12]. The ‘plat-
form’ part of the APC/C is formed by the APC1, APC4,
and APC5 subunits [12, 20, 21]. The actual catalytic sub-
units APC2 (cullin) and APC11 (ring) are located at the
periphery of the platform, in close proximity to the degron-
recognition module, consisting of APC10 and Cdh1 or
Cdc20 (Fig. 1). Binding of the Cdh1/Cdc20 co-activators
to the APC/C induces conformational changes in the three-
dimensional structure of the APC/C [12], and explains why
complex formation between APC/C and Cdh1/Cdc20 ele-
vates catalytic activity [22].
Activation of the APC/C
Activity of the APC/C is regulated predominantly through
binding to its co-activators Cdc20 and Cdh1, as well as
through interaction with its inhibitors Emi1 and the MCC
[11, 19].
The co-activators Cdc20 and Cdh1 have a dual role in
APC/C-mediated degradation of substrates. First, the
WD40 motif in their C-terminal parts is involved in
recruitment of substrates to the APC/C. Second, binding of
Cdc20 or Cdh1 induces a conformation change in the APC/
C to promote ubiquitination. The Cdc20 co-activator
associates with the APC/C upon mitotic entry, and remains
associated until the metaphase-to-anaphase transition. At
that point, Cdc20 is replaced by Cdh1, which remains
associated with the APC/C up until G1 phase (Fig. 2).
Interaction of co-activators with the APC/C is controlled by
Cdk1-mediated phosphorylation. Cdc20 phosphorylation
by Cdk1 is essentially required for its association with the
APC/C and for stimulation of APC/C activity [23, 24]. In
contrast, the effect of CDK-mediated phosphorylation on
Cdh1, is completely opposite. Cdk1-phosphorylated Cdh1
cannot associate with the APC/C, which effectively limits
APC/C-Cdh1 activity until after anaphase onset [23, 24].
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Prior to complex formation between Cdh1 and the APC/
C, Cdk1-mediated phospho-groups need to be removed, a
process that requires phosphatase activity. In budding
yeast, Cdh1 dephosphorylation is governed by the Cdc14
phosphatase, under control by the mitotic exit network
pathway [25, 26]. In human cells, two Cdc14 isoforms
exist, Cdc14A and Cdc14B, and only the Cdc14B isoform
appears to be involved in mitotic dephosphorylation of
Cdh1 [27] (Fig. 2).
In addition to co-activator binding, which is essential to
promote APC/C activation, the APC/C is also subject to
inhibition by Emi1 [28]. During interphase, Emi1 serves as
a pseudo-APC/C substrate as it binds the APC/C at the
D-box receptor and simultaneously interacts with Cdh1
without being degraded. By doing so, Emi1 occupies the
substrate binding site of the APC/C to allow accumulation
of cyclins [29] (Fig. 2). Upon mitotic entry, phosphoryla-
tion of Emi1 by Polo-like kinase-1 (Plk1) creates a
phospho-degron on Emi1, which facilitates degradation of
Emi1 by the Skp1-Cullin1 F-box (SCF)-b-TrCP complex
[28, 30]. Degradation of Emi1 in early mitosis does not
actually appear to be required to allow APC/C activation
during mitosis, as Emi1 depletion does not interfere with
cyclin degradation during mitosis [31]. The main function
of Emi1 therefore appears to be safeguarding cyclin
accumulation prior to mitosis.
Another inhibitor of the APC/C is the mitotic checkpoint
complex (MCC). Until all chromosomes are properly
attached to microtubules from the opposing poles of the
mitotic spindle, Mad1-Mad2 heterodimers are formed at
unattached kinetochores. Once formed, the Mad1-Mad2
dimer induces a change in conformation of a separate
Mad2 copy to produce ‘closed-Mad20 (C-Mad2) [32].
C-Mad2, in conjunction with BubR1 and Bub3, binds and
thereby blocks Cdc20. This latter complex is referred to as
Table 1 Human APC/C subunits and co-activators
APC/C subunits Alternative names Human gene name Function
APC1 – ANAPC1 Scaffold, PC repeats
APC2 – ANAPC2 catalytic core-cullin subunit
APC3 Cdc27 CDC27 Scaffold with TPR motifs
APC4 – ANAPC4 ‘Platform’ subunit
APC5 – ANAPC5 ‘Platform’ subunit
APC6 Cdc16 CDC16 Scaffold with TPR motifs
APC7 – ANAPC7 Scaffold with TPR motifs
APC8 Cdc23 CDC23 Scaffold with TPR motifs
APC10 Doc1 ANAPC10 Substrate recognition
APC11 – ANAPC11 Catalytic core-RING H2 domain
APC12 Cdc26 CDC26 Stabilizes APC6
APC13 – ANAPC13 Stabilizes APC3, APC6 and APC8
APC15 – ANAPC15 Mediated Cdc20/MCC turnover
APC16 – ANAPC16 TPR subunit
Co-activators Alternative names Human gene name Function
Cdc20 P55-Cdc20 CDC20 Substrate recruitment/APC/C activation
Cdh1 Fizzy-related, Hct1 homolog FZR1 Substrate recruitment/APC/C activation

































Fig. 1 The molecular composition of the APC/C. The subunits of the
mammalian APC/C are indicated. APC3, APC6, APC7, and APC8
contain tetracopeptide-repeat (TPR) domains, and together with
APC12 for the TPR lobe. APC1, APC4, and APC5 form the
‘platform’ domain of the APC/C. The catalytic core is composed of
APC11 (Ring) and APC2 (Cullin). APC10 together with one the co-
activators Cdc20/Cdh1 forms the degron-recognition domain
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the MCC, and prevents premature mitotic exit, by inhibit-
ing APC/C-Cdc20-mediated degradation of Cyclin B and
Securin until all chromosomes have been properly attached
to the mitotic spindle [19, 33–36].
Although, clearly, the APC/C is controlled through
binding to activators and inhibitors, post-translational
control by phosphorylation is involved in its regulation as
well. Multiple subunits of the APC/C are phosphorylated at
mitotic onset, including by mitotic kinases Cdk1 and Plk1
[37–39]. Cdk1-mediated phosphorylation events are
required for activation of the APC/C-Cdc20, but seem to be
dispensable for APC/C-Cdh1 activity [24, 39]. By contrast,
phosphorylation of APC/C subunits by Plk1 does not


































Fig. 2 Three waves of APC/C
activation during mitosis. The
APC/C is activated during
mitosis and remains active up
until G1 phase. Three
independent waves of APC/C
activity can be distinguished. 1
APC/C-Cdc20 activity during
prometaphase, which is
unaffected by the spindle
checkpoint, 2 APC/C-Cdc20
activity in metaphase, which is




Identified substrates of each of
the APC/C entities are
indicated. Interphase activation
of the APC/C is precluded by
Emi1 and Cdk2-mediated
phosphorylation of Cdh1
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40, 41]. Nevertheless, phosphorylation of APC/C, as well
as its co-activators and inhibitors appears to be a key
mechanism in controlling the timing of its activation. And
thus, mitotic kinases act in bifurcated ways to ensure rapid
activation of the APC/C during mitotic entry.
Recognition of APC/C substrates
The above-mentioned layers of regulation make that three
different phases of APC/C activity can be distinguished,
and these phases are best characterized by degradation
kinetics of APC/C substrates (Fig. 2). APC/C substrates
require ‘degrons,’ specific amino acids sequences that are
recognized by APC/C-Cdc20 or APC/C-Cdh1, to be effi-
ciently degraded. Most APC/C substrates contain one or
more D-boxes (RXXLXX[I/V]XN) or KEN boxes
(KENXXX[N/D]) [42, 43].
A first wave of APC/C activity is observed upon mitotic
entry, and depends on the Cdc20 co-activator. During
prometaphase, the Cdc20-activated APC/C degrades
Cyclin A and the NIMA-related kinase Nek2A [44–47]. Of
note, degradation of Cyclin A and Nek2A depends on
Cdc20, but is not subject to regulation by the spindle
checkpoint. How exactly these early APC/C-Cdc20 targets
escape regulation by the MCC is not entirely clear, but the
use of alternative degrons appears to be involved.
A second wave of APC/C-Cdc20 activity occurs upon
silencing of the spindle checkpoint, and mediates the
degradation of Cyclin B and Securin. These two APC/C
targets are the only essential targets for cell proliferation
[48]. Degradation of Securin is required for sister chro-
matid separation [49, 50], whereas degradation of Cyclin B
is required for exit from mitosis [51–54]. In line with this
notion, multiple APC genes as well as the CDC20 gene are
essential, whereas Cdh1 is non-essential for survival of
individual cells [55–60].
Once the levels of Cyclin B are decreased below a
critical level, Cdk1 activity ceases and Cdh1 is allowed to
initiate a third wave of APC/C activity. The APC/C-Cdh1
is activated during mitotic exit and targets a range of
proteins, including mitotic cyclins regulators of mitotic
spindle organization, as well as essential S-phase compo-
nents [11, 19]. Through suppressing mitotic cyclins, the
APC/C-Cdh1 is an important factor in the decision to re-
enter a new round of cell division, and ultimately con-
trolling cell fate [61]. In line with this notion, absence of
Cdh1 leads to aberrant up-regulation of Cyclin A levels and
results in premature initiation of replication. So, although
the APC/C-Cdh1 is not essential for cell division of indi-
vidual cells, this does not mean that the APC/C-Cdh1 does
not fulfill an important function, as is also underscored by
the lethal phenotype of the Cdh1 knockout mouse [62].
Cell cycle regulation in situations of DNA damage
As mentioned above, the cell cycle machinery warrants the
timely coordination of the various molecular events in
which duplication and distribution of chromosomes over
daughter cells are managed. In order to ensure that cells are
protected against genomic insults, the cell cycle machinery
is susceptible to external cues. When DNA is damaged, for
instance due to intrinsic factors such as critically short
telomeres or replication stress or extrinsic sources includ-
ing ionizing radiation, cells activate the ‘DNA damage
response’ (DDR) [63, 64].
The DDR detects DNA damage, and coordinates a cell
cycle arrest with the repair of damaged DNA. Situated
upstream in the DDR response, several protein complexes
can detect various aberrant DNA structures. For instance,
the Mre11/Rad50/Nbs1 (MRN) complex binds the ends of
double strand DNA breaks (DSBs) [65], whereas the Rad9-
Rad1-Hus1 (9-1-1) complex is loaded onto DNA with
structural abnormalities, for instance after UV exposure or
stalled replication [66]. Subsequent to detection of DNA
lesions, checkpoint kinases are activated. In response to
DNA DSBs, the Ataxia Telangiectasia Mutated (ATM)
kinase is activated. Conversely, in response to replication
stalling, or otherwise generated stretches of single-stranded
DNA, the ATM and Rad3-related (ATR) kinase is acti-
vated. Both ATM and ATR are members of the
PI(3)Kinase-related kinase (PIKK) family, and can phos-
phorylate an extensive array of substrates, including DNA
repair proteins, the RNA translation machinery and meta-
bolic regulators [67]. More importantly, ATM and ATR
link the detection of DNA damage to stalling of the cell
cycle.
Upon generation of DNA DSBs, ATM phosphorylates
and thereby activates the checkpoint kinase Chk2 [68]. In
turn, Chk2 phosphorylates members of the Cdc25 phos-
phatase family which leads to their inhibition [69, 70].
Under normal conditions, the Cdc25 phosphatases coun-
teract the Myt1 and Wee1 kinases, by removing the
inhibitory phosphate groups on tyrosine 15 (Y15) and
threonine 14 (T14) in Cdk1 and Cdk2 [1, 4, 5, 71, 72].
Consequently, the ATM/Chk2 axis within the DDR pre-
vents Cdc25 activation and keeps Cdk1/2 in a
phosphorylated-inactive-state to prevent cell cycle pro-
gression. Likewise, ATR phosphorylates the Chk1
checkpoint kinases to achieve similar inactivation of the
Cdc25 phosphatases [1–4].
The kinetics of these kinase-driven DDR signaling axes
are fast, and mediate a rapid arrest of cell cycle progression
within minutes after DNA damage induction [5]. This fast-
acting part of the DDR is complemented with a delayed,
yet robust, transcriptional pathway. ATM, as well as the
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ATR, Chk1 and Chk2 kinases, phosphorylate multiple
residues within the N-terminus of the p53 transcription
factor [6–10]. In parallel, the E3 ubiquitin ligase MDM2,
which under physiological conditions ubiquitinates and
thereby marks p53 for proteasomal degradation [11], is also
phosphorylated by ATM. ATM- or ATR-mediated phos-
phorylation of MDM2 prevents the association between
p53 and MDM2, and leads to stabilization of p53 [12, 13].
In turn, p53 promotes transactivation of its many target
genes, including the cyclin-dependent kinase inhibitor
(CKI) p21cip/waf [14, 15] and the cell cycle checkpoint
protein Gadd45 [16, 17]. Although this transcriptional
DNA damage response requires hours to be installed, its
downstream effects can last for days. The combination of a
kinase-driven fast-acting DDR axis with a delayed tran-
scriptional DNA damage response thus constitutes a robust
cellular reaction to maintain genomic integrity. Tem-
porarily arresting cell cycle progression can provide time
for repair of DNA lesions, after which cells can silence
checkpoints to restart the cell cycle [18, 19].
When the levels of DNA damage are beyond repair,
however, affected cells need to be permanently arrested
(senescence) or eliminated through programmed cell death
(apoptosis). Failure to do so is associated with increased
tumorigenesis [20]. How exactly cells make the decision to
enter a permanent cell cycle arrest after DNA damage is
unclear. Recent data have shown that entrance into senes-
cence is dependent on the level of DNA damage, is p53-
dependent and can happen both in G1 and G2 cells [21, 22].
Recently emerging roles of the APC/C-Cdh1
in the response to DNA damage
In line with a role of the APC/C-Cdh1 in degradation of
mitotic regulators, inactivation of the Cdh1 locus in
chicken DT40 cells resulted in accumulation of mitotic
cyclins in G1 cells [23]. Unexpectedly, Cdh1 knock-out
cells failed to maintain a DNA damage-induced G2 cell
cycle checkpoint arrest [23]. These data suggested for the
first time that the APC/C-Cdh1 also has a function in G2
phase of the cell cycle. This role, however, seems to be
restricted to situations in which there is DNA damage.
Indeed, upon irradiation, Cdh1 was shown to associate with
the APC/C, using co-immunoprecipitation assays in cell
line models from several species [23]. Moreover, purified
APC/C from irradiated G2 cells was activated when
assessed using in vitro ubiquitination assays toward Cdc20
[23].
Under normal conditions, the APC/C-Cdh1 is unable to
ubiquitinate substrates in G2 phase and early mitosis. This
is achieved through multiple mechanisms. First, CDK-
mediated phosphorylation of Cdh1 occurs on different
residues prior to the metaphase-to-anaphase transition, and
these phosphorylation events prevent association of Cdh1
with the APC/C [24, 25]. Importantly, a Cdh1 mutant in
which CDK phosphorylation sites were removed activated
the APC/C already in S-phase [25, 26]. Likewise, depletion
of Cyclin A also prematurely activated the APC/C-Cdh1,
suggesting that a Cyclin A/CDK complex is required to
keep APC/C-Cdh1 inactive during interphase [26]. Second,
as also explained previously, the APC/C is kept inactive
during S and G2 phase by Emi1 [27, 28]. Emi1 is expressed
from late G1 onwards, and sterically inhibits the APC/C
[27, 29]. Only during mitotic entry, Emi1 is degraded by
the SCF-b-TrCP [30–32]. The impact of Emi1-mediated
APC/C inhibition becomes apparent after Emi1 depletion:
Cyclins A and B do not accumulate, and cells do not ini-
tiate S-phase, nor enter mitosis [28, 29].
Activation of the APC/C-Cdh1 in response to DNA
damage; How is it accomplished?
Although genetic and biochemical evidence was provided
which indicated that the APC/C-Ch1 can be activated in
response to DNA damage, it is not entirely clear how this is
accomplished mechanistically. Most evidence so far points
at regulation of the phosphorylation status of Cdh1. The
activity of cyclin/CDK complexes is down-regulated after
activation of the DDR, through rapid inactivation of the
Cdc25 phosphatases that under normal circumstances acti-
vate CDKs. However, the level of CDK inactivation that the
kinase-driven DDR axis accomplishes does not seem to be
sufficient for APC/C-Cdh1 activation [33]. Rather, the p53/
p21 transcriptional DDR axis is required for APC/C-Cdh1
activation, since deletion of TP53 or CDKN1A (encoding
p21) abrogated APC/C-Cdh1 activation after DNA damage
[33]. Whether the function of p53 in this context is solely to
lower CDK activity is unclear, as it also leads to down-
regulation of Emi1 and could through this effect also pro-
mote activation of the APC/C-Cdh1 [33].
Besides regulation of CDK kinase activity, the phos-
phatase that removes CDK-mediated phosphorylation
groups appears differentially regulated upon DNA damage
as well. In budding yeast, the Cdc14 phosphatase is
involved in reversing CDK phosphorylation events during
anaphase [34], controlled by the Mitotic Exit Network
(MEN) pathway [35]. As part of this mechanisms, Cdc14 is
released from the nucleolus to promote Cdh1 dephospho-
rylation and ensuing APC/C activation [34, 36]. Human
cells contain two Cdc14 orthologues: Cdc14A and
Cdc14B. Of these two, Cdc14B is localized to nucleoli,
from which it is released during mitosis [37]. In contrast to
yeast, however, Cdc14B in human cells is not essentially
required for mitotic exit [37]. Interestingly, in G2 cells
Cdc14B is released from the nucleolus in response to DNA
damage [38, 39].
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Combined, it seems that three events contribute to APC/
C-Cdh1 activation in G2 cells: (1) down-regulation of CDK
activity in response to DDR activation, (2) p53-dependent
inactivation of APC/C inhibitor Emi1, and (3) the
translocation of Cdc14B phosphatase from the nucleolus to
the nucleoplasm. Many questions about the exact molec-
ular wiring of these pathways, however, remain unsolved
[39]. For instance: is Emi1 degradation required for APC/
C-Cdh1 activation? Another question relates to how
Cdc14B is released from the nucleolus in response to DNA
damage. More interestingly perhaps, it remains unclear
whether these various events are connected.
Although unexplored, a more direct way of APC/C
regulation concerns direct modification of APC/C subunits
in response to DNA damage, through direct phosphoryla-
tion by ATM/ATR. In a large proteomics study to identify
ATM and ATR substrates, APC12 was found to be phos-
phorylated on Ser-78 in response to ionizing radiation [40].
Although it is unclear what the functional impact of this
phosphorylation event is, this residue appears conserved in
mammals, but not in all vertebrates, such as chicken and
frog (data not shown). Although Cdc26/APC12 does not
appear to be directly involved in catalytic activity of the
APC/C, modification of the APC/C in response to DNA
damage might alter the conformation of the APC/C, or
possibly have an impact on its activity or substrate
specificity.
Regulation of the G2/M checkpoint by the APC/C-
Cdh1
Activation of the APC/C-Cdh1 appears to contribute to the
maintenance of a DNA damage-induced G2/M cell cycle
checkpoint. Cdh1 inactivation in DT40 chicken cells leads
to premature checkpoint termination [23]. Although the
APC/C-Cdh1 has many reported targets, the defects in
G2/M checkpoint maintenance were attributed to defective
down-regulation of Plk1. Out of 15 assessed APC/C-Cdh1
targets, only Plk1 showed APC/C-Cdh1-dependent degra-
dation in response to DNA damage. Specifically,
expression of a Plk1 mutant that cannot be targeted by the
APC/C resulted in enhanced mitotic entry in the presence
of DNA damage [38].
The surprising finding that not all APC/C-Cdh1 targets
are down-regulated after DNA damage was at least in part
explained by the action of the deubiquitinating (DUB)
enzyme USP28. The APC/C-Cdh1 target Claspin, for
instance, is protected from APC/C-mediated down-regu-
lation by USP28 [38], and also 53BP1 and Chk2 were
reported to be stabilized by USP28 upon DNA damage
[41]. An additional explanation for selective substrate
engagement of the APC/C-Cdh1 would be the presence of
two distinct pools of APC/C [42]. One pool presumably is
inactive in G2, regardless of the presence of DNA damage,
by virtue of inhibition by Emi1. A second pool would be
inactive in G2 cells due to CDK-mediated phosphorylation.
Only this second pool presumably becomes active upon
DNA damage, due to Cdc14B-mediated dephosphorylation
of Cdh1 and/or down-regulation of CDK activity [42]. This
model is supported by the observation that USP28 deple-
tion does not lead to general degradation of APC/C-Cdh1
targets, and the observation that Emi1 association with the
APC/C does not appear to be controlled by DNA damage
[38].
The APC/C-Cdh1 also targets other proteins that are
crucial for the G2/M transition, which could explain the
effects of Cdh1 depletion on checkpoint maintenance. The
MEF2C and FoxM1 transcription factors, for instance, are
Cdh1 targets and promote the expression of multiple cell
cycle genes including 14-3-3c, Gadd45b, and p21 for
MEF2C; and Cyclin B1 and Plk1 for FoxM1 [43–45].
Whether MEF2C and FoxM1 are degraded in a Cdh1-de-
pendent fashion in response to DNA damage, however, is
not known. Another APC/C-Cdh1 target is the Wip1
phosphatase [46]. Wip1 can reverse ATM/ATR-mediated
phosphorylation groups, for instance on H2AX and p53,
and is involved in the restart of the cell cycle when DNA
has been repaired [47–50]. Proteolytic down-regulation of
Wip1 could aid in maintaining a cell cycle arrest in situa-
tions of DNA damage, although this hypothesis has yet to
be confirmed experimentally.
Regulation of DNA repair by the APC/C-Cdh1
In addition to its effects on G2 checkpoint behavior, the
APC/C-Cdh1 has also been implicated in modulating DNA
repair.
Concerning the repair of DNA double strand breaks
(DSBs), cells can choose between two fundamentally dif-
ferent repair pathways. Repair through error prone non-
homologous end-joining (NHEJ) can occur throughout the
cell cycle, and ligates DNA ends in a sequence-indepen-
dent fashion [51]. Alternatively, cells can repair DSBs
using homologous recombination (HR). Since this process
uses sister chromatids as a template for error-free repair,
HR is restricted to S/G2 phase of the cell cycle [52]. A key
step in HR is the formation of single-stranded (ss)DNA
through 5’-to-3’ end resection. This process is facilitated
by the MRN complex, in conjunction with CtIP [53]. As
DNA ends with long ssDNA tails are not substrates for
end-joining repair, the process of DNA end resection is the
key decisive point where repair is committed to HR repair.
In fission yeast, the Rad54 homolog rhp54 was shown to
be a target of the APC/C-Cdh1 [54]. Rad54 is a DNA-
dependent ATPase and is critically required for HR.
Expression of a non-degradable Rhp54 mutant leads to
Controlling the response to DNA damage by the APC/C-Cdh1 955
123
aberrant HR and to increased sensitivity to a range of DNA
damaging agents, including bleomycin and UV [54].
However, no APC/C-dependent degradation of the S.
cerevisiae Rad54 nor human Rad54A or Rad54B was
observed, suggesting the observed phenotype is species-
specific [54]. Upstream in the HR pathways, the Receptor-
Associated Protein 80 (Rap80) forms a complex with
Brca1, and facilitates the recruitment of Brca1 to sites of
DNA damage [55]. During mitotic exit, Rap80 is degraded
in an APC/C-dependent fashion, which is thought to pre-
vent illegitimate recombination during G1 phase of the cell
cycle [56].
In a proteomic screen, the homologous recombination
DNA repair protein CtIP was identified as a APC/C-Cdh1
target [57]. Specifically, CtIP was down-regulated in an
APC/C-Cdh1-dependent manner, both during mitotic exit
as well as in response to DNA damage. Notably, expression
of a non-degradable CtIP mutant resulted in extended
retention of CtIP at sites of DNA damage, caused elevated
levels of DNA end resection, and ultimately interfered with
normal DNA repair through recombination [57]. From
these data, it appears that APC/C activation at late time
points after DNA damage is required for proper DNA
repair. This observation is in line with data from Cdc14B
knockout cells. Loss of Cdc14B, which should lead to an
inability to activate the APC/C-Cdh1 in response to DNA
damage, resulted in defective DNA repair [58].
The APC/C-Cdh1 has also been implicated in control-
ling replication. Prior to S-phase initiation, the de-
ubiquitinating enzyme USP1 is down-regulated by the
APC/C-Cdh1, which allows PCNA to be mono-ubiquiti-
nated in response to UV [59]. Thus, the APC/C-Cdh1 is
required to equip cells with the ability to deal with
potential replication-blocking lesions in the ensuing
S-phase. During replication stress, exposed ssDNA acti-
vates the ATR kinase, which phosphorylates the Rad17
protein [60, 61]. Subsequently, Rad17 is thought to be
involved in the loading of the Rad9-Rad1-Hus1 (9-1-1)
checkpoint-sliding clamp onto DNA, as well as the acti-
vation of the Claspin/Chk1 complex to facilitate cell cycle
checkpoint activation and repair [62, 63]. Rad17 was
shown to be degraded in response to UV exposure, in an
APC/C-Cdh1-dependent fashion [64]. Rather than con-
trolling DNA repair, damage-induced degradation of
Rad17 appears to be required for cell cycle re-entry [64].
Other APC/C-Cdh1-mediated effects during the
response to replication stress include the stabilization of the
Cdc7, as well as its co-factor: activator of S-phase kinase
(ASK, also referred to as Dfb4). In response to a hydrox-
yurea-induced replication arrest, Cdc7 and ASK are
stabilized. Cdc7/ASK activity, in turn, stimulates DNA
lesion bypass, also known as translesion synthesis (TLS)
[65]. Mechanistically, Cdh1 was shown to promote its own
degradation, in a manner that was stimulated by Chk1.
How exactly Chk1 promotes the inactivation of Cdh1 is not
clear [65]. Also the APC/C-Cdh1 target PCNA-associated
factor-15 (p15-PAF) is involved in TLS [66]. In response
to replication stalling, p15-PAF is removed from chromatin
by proteasomal degradation. Notably, whereas the APC/C-
Cdh1 is responsible for p15-PAF degradation during G1
phase of the cell cycle [67, 68], a different ubiquitin ligase
is responsible for p15-PAF degradation upon replication
stress, as this process is independent of its APC/C
destruction boxes [66]. Additional genes that function in
S-phase checkpoint pathways, and were shown to be tar-
geted by the APC/C, include Tos4 and Pdr3 in budding
yeast, although the implications of APC/C-mediated reg-
ulation of these proteins remains to be established [69].
APC/C and Cdh1 in cancer
Proper cell cycle control is key in preventing oncogenic
transformation. It has been long recognized that Cdh1 is
instrumental in establishing the G1 phenotype after a round
of cell division. Cdh1 is required to down-regulate com-
ponents of the replication and mitotic spindle machinery,
and APC/C-Cdh1 activity in G1 phase prevents the accu-
mulation of essential genes for another round of DNA
replication. In line with this notion, inactivation of mouse
Fzr1 gene (encoding Cdh1) prevented the terminal differ-
entiation of neuronal progenitors and resulted in increased
proliferation of neuronal stem cells, and conversely,
defective neurogenesis [70, 71]. As a consequence of
unscheduled S-phase entry, Cdh1 loss leads to replication
stress and ensuing genomic instability [72], a commonly
recognized driver of oncogenesis. The latter observations
underscore the potential tumor-suppressive function of
Cdh1. In good agreement with this model, Cdh1 inactiva-
tion leads to the development of several cancers in mice
[71], and low Cdh1 expression was observed in multiple
cancer cell lines [73]. Also, the PTEN tumor suppressor
gene was shown to stimulate association of Cdh1 with the
APC/C [74], and hence, the frequently observed loss of
PTEN may indirectly result in impaired APC/C-Cdh1
function in cancers. Likewise, the tumor-suppressor sirtuin
gene SIRT2 was shown to promote APC/C-Cdh1 function
through acetylation of Cdh1, and again may explain tumor-
suppresive effects of indirect APC/C-Cdh1 inactivation
[75].
Whether the tumor-suppressive function of Cdh1 also
involves its role in controlling cell fate after DNA damage
is unclear. The observation that APC/C-Cdh1 degrades the
histone methyltransferases G9a and GLP in response to
DNA damage may point at such a role [76]. Specifically,
G9a and GLP are degraded by the APC/C-Cdh1 in a
Cdc14B- and p21-dependent fashion. Both G9a and GLP
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are responsible for positioning histoneH3-Lysine-9 mono-
and di-methyl marks, epigenetic marks of gene silencing.
Consequently, DNA damage leads to a global decrease of
H3K9 methylation, along with elevated expression of IL6
and IL8, two interleukins that contribute to the senescence
phenotype [76]. Importantly, this function of the APC/C
was uncovered in response to oncogene-induced replication
stress, indicating that Cdh1 prevents outgrowth of cells
with oncogene-induced DNA damage. Therapeutically, the
increased levels of replication stress in cancer cells with
inactivated Cdh1 may create sensitivity to targeted agents
that target the replication checkpoint, such as inhibitors of
Wee1, ATR or Chk1. In contrast, loss of Cdh1 was recently
shown to bypass the dependency of cancer cells on Cdk4/6
[77], indicating that Cdh1 loss may constitute an exclusion
criterion for treatment with the recently developed Cdk4/6
inhibitors, or could be a mechanism of acquired resistance
to such drugs.
Although some cancer cell lines were reported to have
loss of Cdh1 expression, analysis of TCGA data shows that
APC/C components and Cdh1 are not commonly inacti-
vated in human cancers. This may point at an essential role
of the APC/C and/or APC/C cofactors for the growth of
some cancers. Indeed, using an siRNA-based screen-
ing method, loss of APC/C activity was shown to be
synthetic lethal with loss of chromosome cohesion. As a
consequence, therapeutic targeting of the APC/C may be
beneficial in cohesion-defective cancers [78]. In this
context, it is important that small molecule inhibitors of the
APC/C have been developed (proTAME and APCin),
which in combination block total APC/C activity [79].
Concluding remarks
Increasingly, the APC/C-Cdh1 is recognized to be involved
in the cellular response to DNA damage. The contours of
the mechanisms that underlie APC/C-Cdh1 activation have
become apparent, with Cdc14B and the p53/p21 axis being
clearly involved (Fig. 3). Of note, many studies in this area
employ high levels of DNA damage, which exceed phys-
iological levels of DNA lesions, and may only reflect
situations of cancer treatment with genotoxic agents.
Nevertheless, recent studies using oncogene-induced DNA
damage and persistent telomere damage confirmed the
activation of the APC/C-Cdh1 [76, 80], and established
similar genetic requirement, i.e., the presence of Cdc14 and
p53/p21 [76]. Finally, the observation that Cdh1 inactiva-
tion leads to high levels of genomic instability and
accumulation, underscores the relevance of Cdh1 in
maintaining genomic integrity even in unchallenged con-
ditions [71, 81, 82] (Fig. 4).
Concluding, the APC/C-Cdh1 constitutes one of the
effector pathways of the response to DNA damage. Further
research is warranted to better understand the mechanisms
that underpin APC/C-Cdh1 activation after DNA damage,
and which consequences it has. Uncovering these



































Fig. 3 Roles of the APC/C-Cdh1 in response to DNA damage.
During an unperturbed interphase, the APC/C is not active due to 1
binding of Emi1, 2 phosphorylation of Cdh1 by Cdk2, and 3 the
inability of Cdc14B to dephosphorylate Cdh1. In response to DNA
damage in G2 cells, 1 the DDR kinases ATM and ATR mediate
activation of p53, which leads to Emi1 down-regulation. 2 ATM/ATR
and p53 inactivate Cdk2 activity, and 3 Cdc14B is released from the
nucleolus through unknown mechanisms. Combined, these mecha-
nisms lead to activation of the APC/C-Cdh1
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regulatory mechanisms and phenotypes may provide fur-
ther insight into how cells are wired to cope with genomic
stress, and how these mechanisms may be altered during
tumorigenesis and can potentially be exploited during
cancer treatment.
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